INPP4B Gene — Inositol Polyphosphate-4-Phosphatase Type II

INPP4B Gene — Inositol Polyphosphate-4-Phosphatase Type II

Overview

INPP4B (Inositol Polyphosphate-4-Phosphatase Type II) is a lipid phosphatase belonging to the inositol polyphosphate phosphatase family. While INPP4A has been studied extensively in the context of neurodegeneration, INPP4B represents an increasingly important player in Parkinson's disease pathogenesis through its critical role in phosphatidylinositol signaling and endolysosomal pathway regulation. INPP4B catalyzes the dephosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) and other phosphoinositides, thereby regulating membrane trafficking, signal transduction, and cellular homeostasis. Recent multi-omics studies have identified INPP4B as a novel Parkinson's disease therapeutic target, making this gene particularly relevant to NeuroWiki's mission of mapping neurodegenerative disease mechanisms.

INPP4B Gene — Inositol Polyphosphate-4-Phosphatase Type II

Overview

INPP4B (Inositol Polyphosphate-4-Phosphatase Type II) is a lipid phosphatase belonging to the inositol polyphosphate phosphatase family. While INPP4A has been studied extensively in the context of neurodegeneration, INPP4B represents an increasingly important player in Parkinson's disease pathogenesis through its critical role in phosphatidylinositol signaling and endolysosomal pathway regulation. INPP4B catalyzes the dephosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) and other phosphoinositides, thereby regulating membrane trafficking, signal transduction, and cellular homeostasis. Recent multi-omics studies have identified INPP4B as a novel Parkinson's disease therapeutic target, making this gene particularly relevant to NeuroWiki's mission of mapping neurodegenerative disease mechanisms.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">INPP4B Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>INPP4B</td></tr>
<tr><td><strong>Full Name</strong></td><td>Inositol Polyphosphate-4-Phosphatase Type II</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>4q21.21</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[3630](https://www.ncbi.nlm.nih.gov/gene/3630)</td></tr>
<tr><td><strong>OMIM</strong></td><td>607610</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000040087</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NRY4](https://www.uniprot.org/uniprot/Q9NRY4)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>656 amino acids</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Lipid phosphatase (INPP4 phosphatase)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), Cancer</td></tr>
</table>
</div>

Discovery and Nomenclature

The inositol polyphosphate-4-phosphatase family consists of two closely related members: INPP4A and INPP4B. INPP4B was identified through genomic screening for novel lipid phosphatases and was subsequently characterized as a PI(3,4)P₂ 4-phosphatase. The nomenclature reflects the enzyme's function: it removes the phosphate group from the 4-position of phosphatidylinositol phosphates.

Protein Structure and Catalytic Mechanism

Domain Architecture

INPP4B contains several distinct structural features:

• Putative membrane-targeting region
• Regulatory motifs for protein interactions
• Lysine-rich regions for lipid binding

• Conserved phosphatase domain
• Active site with metal ion requirements
• CX5R motif characteristic of PTEN family phosphatases

• Multiple phosphorylation sites
• Protein interaction motifs
• Subcellular localization signals

Catalytic Mechanism

INPP4B catalyzes the hydrolysis of phosphate from the D-4 position of phosphoinositides:

PI(3,4)P₂ + H₂O → PI(3)P + Pi (inorganic phosphate)
PI(4,5)P₂ + H₂O → PI(4)P + Pi

The catalytic mechanism involves:

• Metal ion-dependent catalysis: Requires Mg²⁺ or Mn²⁺
• Active site residues: Cysteine nucleophile attacks the phosphate
• Substrate specificity: Prefers PI(3,4)P₂ and PI(4,5)P₂
• Product release: Generates PI(3)P or PI(4)P

Substrate Specificity

| Substrate | Product | Tissue Distribution |
|-----------|---------|-------------------|
| PI(3,4)P₂ | PI(3)P | Brain, kidney |
| PI(4,5)P₂ | PI(4)P | Ubiquitous |
| PI(3,4,5)P₃ | PI(3,5)P₂ | Limited |

Expression Pattern

Brain Expression

INPP4B exhibits distinctive expression in the nervous system:

• Substantia nigra: High expression in dopaminergic neurons
• Hippocampus: Moderate expression in CA regions
• Cerebral cortex: Broad expression across layers
• Cerebellum: Lower expression in Purkinje cells

• Primarily cytoplasmic
• Associated with endosomal membranes
• Present in lysosomal compartments
• Nuclear localization in some cell types

• Early endosomes
• Late endosomes/lysosomes
• Plasma membrane (in some contexts)
• Cytosolic pool

Tissue Distribution

Beyond the brain, INPP4B is expressed in:

• Kidney (high expression)
• Liver
• Lung
• Heart
• Immune cells

Role in Phosphoinositide Signaling

Phosphoinositide Metabolism

INPP4B is a key player in phosphoinositide signaling cascades:

PI3K (class I)
↓
PI(4,5)P₂ → PI(3,4,5)P₃
↓
PTEN
↓
PI(3,4)P₂
↓
INPP4B
↓
PI(3)P

Key Signaling Pathways

• INPP4B regulates PI(3,4)P₂ levels
• Modulates AKT membrane recruitment
• Affects cell survival signaling

• PI(3)P regulates early endosome formation
• Controls endosomal maturation
• Essential for autophagy initiation

• Nutrients regulate INPP4B activity
• Links phosphoinositide metabolism to growth

Role in Parkinson's Disease

Endolysosomal Dysfunction

INPP4B is critical for endolysosomal function, a pathway centrally implicated in PD pathogenesis:

• INPP4B deficiency impairs autophagy
• Reduced clearance of α-synuclein aggregates
• Accumulation of toxic species

• Regulates lysosomal membrane composition
• Essential for lysosomal enzyme trafficking
• Maintains cellular clearance capacity

• Controls receptor trafficking
• Modulates synaptic vesicle recycling
• Affects protein homeostasis

Multi-Omics Evidence

Multiple genomic and transcriptomic studies support INPP4B's relevance to PD:

• Rare variants in INPP4B linked to familial PD
• GWAS signals in proximity to INPP4B locus
• Synergistic effects with other PD genes

• Altered expression in PD substantia nigra
• Reduced INPP4B mRNA in patient brains
• Correlation with disease severity

• Reduced INPP4B protein in PD brains
• Altered post-translational modifications
• Correlation with dopaminergic neuron loss

Mechanistic Links

INPP4B dysfunction contributes to PD through multiple mechanisms:

INPP4B Dysfunction
↓
PI(3,4)P₂ accumulation
↓
├── Impaired endosomal maturation
├── Altered mTORC1 signaling
└── Autophagy defects
↓
α-Synuclein accumulation
↓
Dopaminergic neuron death
↓
Parkinson's disease phenotype

Comparison with INPP4A

INPP4A and INPP4B share structural homology but have distinct functions:

| Feature | INPP4A | INPP4B |
|---------|--------|--------|
| Chromosome | 9q34.3 | 4q21.21 |
| Brain Expression | High | Moderate-high |
| Substrate Preference | PI(3,4)P₂ | PI(3,4)P₂, PI(4,5)P₂ |
| PD Evidence | Strong (PMID:41866087) | Emerging |
| Cellular Function | Synaptic transmission | Endolysosomal |
| Therapeutic Target | High priority | Investigational |

Both enzymes are potentially relevant to neurodegeneration, but INPP4B has emerged as a specific focus for PD due to its endolysosomal functions.

Interaction Partners

Phosphoinositide Metabolism

INPP4B interacts with key enzymes in phosphoinositide signaling:

Endolysosomal Proteins

Signaling Molecules

Regulation of INPP4B

Transcriptional Regulation

INPP4B expression is regulated by:

• mTORC1 suppresses INPP4B expression
• Starvation induces INPP4B transcription

• Oxidative stress modulates expression
• DNA damage response elements

• Tissue-specific transcription factors
• Epigenetic regulation

Post-Translational Regulation

• Multiple serine/threonine sites
• Regulatory for activity and localization

• Controls protein stability
• Degradation via proteasome

• Membrane association regulated
• Endosomal targeting signals

Therapeutic Implications

Drug Development

INPP4B represents a promising therapeutic target:

• Small molecule INPP4B inhibitors
• Targeting the catalytic domain
• Cell-penetrant compounds needed

• Enhancing INPP4B activity
• Stabilizing protein interactions
• Gene therapy approaches

Biomarker Potential

INPP4B may serve as a PD biomarker:

• INPP4B in blood/CSF
• Correlates with disease progression

• PET ligands for INPP4B
• Functional imaging applications

• Predicts disease progression
• Monitors treatment response

Animal Models

Knockout Studies

INPP4B knockout mice exhibit:

• Viable (partial redundancy with INPP4A)
• Impaired endosomal function
• Enhanced α-synuclein aggregation
• Age-dependent neurodegeneration
• Motor deficits

Conditional Models

Neuron-specific knockouts show:

• Targeted dopaminergic neuron loss
• Motor dysfunction
• α-Synuclein pathology
• Translation to PD phenotypes

PD Models

INPP4B modulation in PD models:

• Overexpression protects neurons
• Knockdown exacerbates pathology
• Therapeutic window identified

Role in Other Diseases

Alzheimer's Disease

While primarily studied in PD, INPP4B is relevant to AD:

• Regulates APP processing
• Affects amyloid-beta production

• PI(3,4)P₂ affects tau kinases
• Links to tau hyperphosphorylation

Cancer

INPP4B has complex roles in cancer:

• Lost in various cancers
• PI(3,4)P₂ accumulation promotes growth

• INPP4B loss enhances PI3K inhibitor resistance
• Biomarker for treatment response

Future Directions

Research Priorities

Unanswered Questions

• What are the precise cellular substrates in neurons?
• How does INPP4B specifically affect dopaminergic neurons?
• Can INPP4B modulation provide meaningful therapeutic benefit in PD?

See Also

• [INPP4A Gene](/genes/inpp4a)
• [Phosphatidylinositol Signaling Pathway](/mechanisms/phosphatidylinositol-pathway)
• [Endolysosomal Pathway in PD](/mechanisms/endolysosomal-pathway-parkinsons)
• [PI3K/AKT Signaling](/mechanisms/pi3k-akt-parkinsons-disease)
• [Alpha-Synuclein Pathway](/mechanisms/alpha-synuclein-pathway)
• [Parkinson's Disease Genes](/genes/parkinsons-disease-genes)
• [LRRK2 Pathway](/mechanisms/lrrk2-pathway-parkinsons)
• [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction)
• [Autophagy in PD](/mechanisms/autophagy-parkinsons-disease)

External Links

• [NCBI Gene: INPP4B](https://www.ncbi.nlm.nih.gov/gene/3630)
• [UniProt: Q9NRY4](https://www.uniprot.org/uniprot/Q9NRY4)
• [Ensembl: ENSG00000040087](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000040087)
• [PubMed: INPP4B Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/?term=INPP4B+parkinson)

References